Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV; Women's Health Initiative Investigators.

Diabetologia. 2004 Jul;47(7):1175-87. Epub 2004 Jul 14.

PMID:
15252707
[PubMed - indexed for MEDLINE]
2.

The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial.

Bonds DE, Lasser N, Qi L, Brzyski R, Caan B, Heiss G, Limacher MC, Liu JH, Mason E, Oberman A, O'Sullivan MJ, Phillips LS, Prineas RJ, Tinker L.

Diabetologia. 2006 Mar;49(3):459-68. Epub 2006 Jan 27.

PMID:
16440209
[PubMed - indexed for MEDLINE]
3.

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

Ann Intern Med. 2003 Jan 7;138(1):1-9.

PMID:
12513038
[PubMed - indexed for MEDLINE]
4.

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.

PMID:
12771113
[PubMed - indexed for MEDLINE]
5.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

JAMA. 2003 Oct 1;290(13):1729-38.

PMID:
14519707
[PubMed - indexed for MEDLINE]
6.

Estrogen plus progestin and risk of venous thrombosis.

Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

JAMA. 2004 Oct 6;292(13):1573-80.

PMID:
15467059
[PubMed - indexed for MEDLINE]
7.

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

JAMA. 2004 Jun 23;291(24):2947-58.

PMID:
15213206
[PubMed - indexed for MEDLINE]
8.

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators.

J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.

PMID:
16174858
[PubMed - indexed for MEDLINE]
Free Article
9.

Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.

Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL.

Am J Clin Nutr. 2005 Sep;82(3):651-6.

PMID:
16155280
[PubMed - indexed for MEDLINE]
Free Article
10.

The effects of hormone replacement therapy on plasma lipids in type II diabetes.

Manwaring P, Morfis L, Diamond T, Howes LG.

Maturitas. 2000 Mar 31;34(3):239-47.

PMID:
10717490
[PubMed - indexed for MEDLINE]
11.

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ; WHI Investigators.

JAMA. 2003 May 28;289(20):2673-84.

PMID:
12771114
[PubMed - indexed for MEDLINE]
12.

Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.

Howard BV, Hsia J, Ouyang P, Van Voorhees L, Lindsay J, Silverman A, Alderman EL, Tripputi M, Waters DD.

Circulation. 2004 Jul 13;110(2):201-6. Epub 2004 Jun 28.

PMID:
15226212
[PubMed - indexed for MEDLINE]
Free Article
13.

Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.

Shadoan MK, Anthony MS, Rankin SE, Clarkson TB, Wagner JD.

Metabolism. 2003 Sep;52(9):1085-91.

PMID:
14506611
[PubMed - indexed for MEDLINE]
14.

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA; Women's Health Initiative Investigators.

Lancet. 2009 Oct 10;374(9697):1243-51. doi: 10.1016/S0140-6736(09)61526-9. Epub 2009 Sep 18.

PMID:
19767090
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A; WHI Investigators.

JAMA. 2003 Jun 25;289(24):3243-53.

PMID:
12824205
[PubMed - indexed for MEDLINE]
16.

Effects of estrogen with and without progestin on urinary incontinence.

Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG.

JAMA. 2005 Feb 23;293(8):935-48.

PMID:
15728164
[PubMed - indexed for MEDLINE]
17.

Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.

Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL.

Obstet Gynecol. 2006 Aug;108(2):410-9.

PMID:
16880313
[PubMed - indexed for MEDLINE]
18.

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.

PMID:
16815651
[PubMed - indexed for MEDLINE]
19.

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].

Veerus P, Hovi SL, Fischer K, Rahu M, Hakama M, Hemminki E.

Maturitas. 2006 Sep 20;55(2):162-73. Epub 2006 Feb 28.

PMID:
16504428
[PubMed - indexed for MEDLINE]
20.

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.

Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR; Women's Health Initiative Investigators.

Obstet Gynecol. 2005 May;105(5 Pt 1):1063-73.

PMID:
15863546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk